Scarica l'app Stockscreener
32.58
1.46%
0.47
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$32.11
Aprire:
$32.21
Volume 24 ore:
1.23M
Relative Volume:
2.60
Capitalizzazione di mercato:
$980.96M
Reddito:
$1.37B
Utile/perdita netta:
$54.85M
Rapporto P/E:
18.38
EPS:
1.7729
Flusso di cassa netto:
$123.71M
1 W Prestazione:
-5.32%
1M Prestazione:
-11.01%
6M Prestazione:
-19.34%
1 anno Prestazione:
-37.44%
Intervallo 1D:
$32.11
$32.92
Intervallo di 1 settimana:
$31.84
$35.50
Portata 52W:
$31.84
$56.63
Conmed Corp Stock (CNMD) Company Profile
Nome
Conmed Corp
Settore
Industria
Telefono
727-214-2974
Indirizzo
11311 CONCEPT BOULEVARD, LARGO, NY
Compare CNMD vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CNMD
Conmed Corp
|
32.58 | 980.96M | 1.37B | 54.85M | 123.71M | 1.7729 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Conmed Corp Stock (CNMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-17 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-06-12 | Downgrade | Needham | Buy → Hold |
| 2025-04-28 | Downgrade | Stifel | Buy → Hold |
| 2025-02-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-02-01 | Reiterato | Needham | Buy |
| 2023-05-22 | Iniziato | CL King | Buy |
| 2023-03-27 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-03-21 | Iniziato | Wells Fargo | Equal Weight |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-03-02 | Ripresa | BofA Securities | Neutral |
| 2021-10-06 | Aggiornamento | Needham | Hold → Buy |
| 2021-07-15 | Iniziato | UBS | Buy |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2019-11-26 | Downgrade | Needham | Buy → Hold |
| 2019-11-12 | Iniziato | JP Morgan | Overweight |
| 2019-10-31 | Reiterato | Needham | Buy |
| 2019-10-04 | Reiterato | Needham | Buy |
| 2019-08-22 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2019-04-18 | Iniziato | Stifel | Buy |
| 2019-04-16 | Reiterato | Needham | Buy |
| 2019-01-23 | Reiterato | Needham | Buy |
| 2018-10-16 | Iniziato | Barclays | Equal Weight |
| 2018-08-07 | Reiterato | Needham | Buy |
| 2018-08-02 | Reiterato | Needham | Buy |
| 2018-04-26 | Reiterato | Needham | Buy |
| 2018-02-01 | Reiterato | Needham | Buy |
| 2017-07-27 | Reiterato | Needham | Buy |
| 2017-04-27 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2017-04-27 | Reiterato | Needham | Buy |
| 2016-11-18 | Reiterato | Needham | Buy |
| 2016-07-28 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| 2016-04-28 | Reiterato | Needham | Buy |
| 2015-10-22 | Reiterato | Northland Capital | Market Perform |
Mostra tutto
Conmed Corp Borsa (CNMD) Ultime notizie
CONMED Corp. Stock Plummets to New 52-Week Low of $31.86 - MarketsMojo
CONMED Corp. Stock Hits Day Low of $31.86 Amid Price Pressure - MarketsMojo
Conmed Corp (CNMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CONMED Appoints John E. Gallagher as New Chief Financial Officer, Effective July 2026 - Minichart
Conmed Corp (CNMD) Valuation: PE, PB & Fair Value Analysis - TradingKey
Conmed Corp (CNMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Conmed Corp (CNMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Conmed Corp (CNMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Conmed Corp (CNMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Conmed Corp (CNMD) Institutional Confidence - TradingKey
Conmed Corp (CNMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Conmed Corp (CNMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Conmed names John Gallagher as CFO effective July 15 - Investing.com
CONMED names John E. Gallagher as EVP & CFO, Patrick Beyer steps down as interim PFO - TradingView
CONMED (NYSE: CNMD) hires John Gallagher as CFO with equity-heavy pay - Stock Titan
CONMED picks John Gallagher as CFO in July leadership change - Stock Titan
Conmed Corporation stock hits 52-week low at 32.1 USD - Investing.com
Discipline and Rules-Based Execution in CNMD Response - Stock Traders Daily
CONMED Corp stock (US2074101013): Medtech mid-cap in focus after latest earnings and guidance update - AD HOC NEWS
CONMED Corp stock (US2074101013): medtech growth story after latest earnings update - AD HOC NEWS
CONMED to Repurchase $645.2 Million of 2027 Convertible Notes for $637.2 Million Cash - TradingView
CONMED (CNMD) to buy back $645.2M of 2.25% convertible notes due 2027 - Stock Titan
Director at CONMED (NYSE: CNMD) exercises 668 RSUs and receives 5,772-unit equity award - Stock Titan
CONMED (NYSE: CNMD) director gets 5,772 RSUs, converts 668 units - Stock Titan
Director at CONMED (NYSE: CNMD) receives 5,772 RSUs under 2025 incentive plan - Stock Titan
CONMED (NYSE: CNMD) director awarded 5,772 RSUs and exercises 668 into shares - Stock Titan
Director Mark Kaye receives 5,772 RSUs at CONMED (NYSE: CNMD) - Stock Titan
CONMED (NYSE: CNMD) director awarded 5,772 RSUs and converts 668 into common stock - Stock Titan
CONMED (NYSE: CNMD) interim controller details RSU and stock option holdings - Stock Titan
CONMED (CNMD) interim finance chief reports initial stock and option holdings - Stock Titan
Q1 Earnings Outperformers: CONMED (NYSE:CNMD) And The Rest Of The Surgical Equipment & ConsumablesDiversified Stocks - Yahoo Finance
CONMED Board Refresh And Governance Changes Feed Into Valuation Debate - Yahoo Finance
CONMED Corporation Executes First Omnibus Amendment and Increased Facility Activation Notice to Eighth Amended and Restated Credit Agreement - Minichart
Here's Why You Should Retain CONMED Stock in Your Portfolio Now - Yahoo Finance
Conmed secures $450 million term loan facility to repurchase convertible notes - Investing.com
Conmed Secures $450 Million Delayed-Draw Term Loan With JPMorgan to Repurchase 2026 Notes - TradingView
CONMED (NYSE: CNMD) secures $450M term loan to manage 2026 notes - Stock Titan
Why Is Conmed (CNMD) Down 3.1% Since Last Earnings Report? - Yahoo Finance
Clip Applicator Market Will Generate Booming Growth - openPR.com
(CNMD) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
CONMED Corp stock (US2074101013): focus on growth after latest quarterly results - AD HOC NEWS
CONMED Corporation Announces Results of 2026 Annual Meeting, Amended By-Laws, and Director Compensation Updates - Minichart
Conmed appoints two directors to board effective July 1 - Investing.com
Celine Martin and Jeff Mirviss join ConMed board; Kimberly Lockwood named interim controller - TradingView
New CONMED (NYSE: CNMD) directors, bylaw changes and 2026 vote outcomes - Stock Titan
J&J and Boston Scientific veterans join CONMED's board - Stock Titan
CONMED Corporation Appoints Celine Martin and Jeff Mirviss to its Board of Directors - Yahoo Finance
CONMED Corp stock (US2074101013): shares react to Q1 2026 results and updated full-year outlook - AD HOC NEWS
Is the Options Market Predicting a Spike in CONMED Stock? - Yahoo Finance UK
Oppenheimer Asset Management Inc. Has $1.27 Million Stock Holdings in CONMED Corporation $CNMD - MarketBeat
Does CONMED (CNMD) Refocusing Away From Gastroenterology Clarify Its Long-Term Surgical Growth Story? - Yahoo Finance
Conmed Corp Azioni (CNMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):